700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
|FibroGen, Inc., USA|
|ScientificTracks Abstracts: J Clin Trials|
|Like many marriages, the sponsor/CRO relationship is often fraught with strife and adversity. These conflicts typically center around issues including lack of good communications, misaligned expectations, and other common challenges. This presentation explores common pet peeves frequently observed and experienced by both sides. Real-life case studies/anecdotes from various companies will be used and respective conflicts and resolutions will be examined in detail. Common lessons learned that may be applied to current and future sponsor/CRO relationships will be discussed.|
Chris Chan is an Executive Director of R&D Finance at FibroGen, Inc., and has over 25 years of industrial experience, including 20 managing clinical trial and R&D finances for biopharmaceutical companies of various sizes. He holds an MBA from UC Berkeley’s Haas School of Business and is a Certified Management Accountant (CMA) and Certified Financial Manager (CFM). He served as speaker and chair at numerous industry conferences, and has authored multiple published articles on clinical trials budgeting, accruals, and outsourcing.
|PDF | HTML|